Stock overview
Protagonist Therapeutics Inc.
Explore the company, reported ownership, price history, and available source evidence.
PROTAGONIST THERAPEUTICS INC (PTGX) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $127.16
- · PTGX
- Tracked holders
- 3 funds
- Latest available 13F per fund
PTGX · USD
Price
Close · Nov 18, 2026
- Range low
- $124.67
- Range high
- $144.85
- Observations
- 23
- Session date
- Nov 18, 2026
Oct 19, 2026–Nov 18, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Renaissance Technologies largest tracked holder Q3 2026 · filed Nov 12, 2026 · SEC filing | Newly reported 26'Q3 | $10,843,881 | 0.01% |
| Gotham Asset Management position history Q3 2026 · filed Nov 16, 2026 · SEC filing | +250% 26'Q3 | $9,199,835 | 0.02% |
| Polen Capital Management position history Q3 2026 · filed Nov 13, 2026 · SEC filing | −8% 26'Q3 | $2,953,477 | 0.03% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market